More on SPPI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- Dividends

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SPPI Balance Sheet

Click line-items for a historical chart and %
Current Assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net of allowance for doubtful accounts of $630 and $339, respectively
Inventories, net
Prepaid expenses and other current assets
Total current assets
Investments
Property and equipment, net
Intangible assets, net
Other assets
TOTAL ASSETS
Current Liabilities:
Accounts payable and other accrued obligations
Accrued compensation and related expenses
Deferred revenue
Common stock warrant liability
Accrued drug development costs
Total current liabilities
Capital lease obligations
Deferred revenue and other credits--less current portion
Zevalin related contingent obligations
Total liabilities
Commitments and contingencies
Stockholders' Equity:
Preferred stock value
Common stock, $0.001 par value--175,000,000 shares authorized; 52,947,221 and 51,459,284 issued and outstanding at June 30, 2011 and December 31, 2010, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' equity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Series E convertible preferred stock
Stockholders' Equity:
Preferred stock value